Anavar prijs was reported in approximately 12% of pediatric patients receiving somatropin in clinical trials. Hypertension (3-8%) and chest pain (unspecified) (5%) have been reported in patients treated with somatropin in clinical trials. Flu like symptoms have been reported in approximately 4-23% of somatropin-treated patients in clinical trials. Discontinuing treatment
